Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

NCT00598169 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: bortezomib
DRUG: carboplatin
DRUG: dexamethasone
DRUG: etoposide
DRUG: ifosfamide
GENETIC: polymerase chain reaction
GENETIC: western blotting

Sponsor

AIDS Malignancy Consortium

Collaborators

[object Object]
[object Object]